Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$27,039,170
+$276,902 QoQ
Shares Held
106,466
-2.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.05%
of 13F equity value
Holder Rank
#629
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callahan Advisors, LLC holds $70,085,621 across 7 Drug Manufacturers - General names. JNJ ranks #1 (38.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
106,466 | $27,039,170 | |
| 2 | LLY |
ELI LILLY & Co
|
21,791 | $26,136,781 | |
| 3 | PFE |
Pfizer Inc
|
471,052 | $11,342,932 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,700 | $2,916,950 | |
| 5 | ABBV |
AbbVie Inc.
|
5,488 | $1,381,000 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,089 | $869,428 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,161 | $399,360 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,039,170 | 106,466 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $26,762,268 | 109,484 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $24,951,754 | 120,569 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $22,941,645 | 123,728 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $18,862,792 | 123,488 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $20,738,623 | 125,052 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $17,746,175 | 122,709 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $19,162,298 | 118,242 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $17,645,750 | 120,729 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $18,720,362 | 118,341 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $18,316,636 | 116,860 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $18,297,665 | 117,481 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $19,878,124 | 120,095 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $18,301,470 | 118,074 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $21,698,979 | 122,836 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $19,838,111 | 121,438 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,201,439 | 119,438 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $21,132,905 | 119,240 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $20,062,576 | 117,277 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $18,449,437 | 114,238 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $18,478,391 | 112,167 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $18,272,268 | 111,179 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $17,513,403 | 111,281 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $16,814,953 | 112,943 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $15,992,443 | 113,720 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $14,889,811 | 113,550 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||